BioCorRx
高管
查看带有其 6 名主要高管的组织结构图
BioCorRx 搜索最多的简介
- Lourdes Felix, Chief Executive Officer, Chief Financial Officer an...
- Joe Galligan, Director
- Harsha Murthy, Director
创建提醒
跟踪 BioCorRx 的高管变动
健康
BioCorRx 拥有 1,994 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、UnitedHealthcare (美国(美洲)) 和 Siemens Healthineers (德国)。
Popular M&A news in 健康
- Oura Health 刚刚宣布为 200 筹款数百万美元。 (公布2024十二月20号).
- Neuronetics 已收购 Greenbrook TMS (公布2024十二月10号).
- Cleerly 刚刚宣布为 106 筹款数百万美元。 (公布2024十二月9号).
健康 行业的其他推荐联系人
消息
BioCorRx 的最新新闻稿
- BioCorRx Reports Business Update for the Second Quarter of 2024 :: BioCorRx, Inc. (BICX)
- BioCorRx Reports Business Update for the First Quarter of 2024 :: BioCorRx, Inc. (BICX)
- BioCorRx Reports Business Update for 2023 :: BioCorRx, Inc. (BICX)
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia :: BioCorRx, Inc. (BICX)
- BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD :: BioCorRx, Inc. (BICX)
- BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors :: BioCorRx, Inc. (BICX)
- BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President :: BioCorRx, Inc. (BICX)
- BioCorRx Reports Business Update for the Third Quarter of 2023 :: BioCorRx, Inc. (BICX)
- BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder :: BioCorRx, Inc. (BICX)
- Press Releases :: BioCorRx, Inc. (BICX)
- View more press releases Close
通过电子邮件
